Class information for:
Level 1: COST EFFECTIVENESS ANALYSIS//ECONOMIC EVALUATION//PHARMACOECONOMICS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
4456 1782 31.4 60%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
320 3       AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY 39312
1726 2             HEALTH TECHNOLOGY ASSESSMENT//INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE//PRIORITY SETTING 6593
4456 1                   COST EFFECTIVENESS ANALYSIS//ECONOMIC EVALUATION//PHARMACOECONOMICS 1782

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 COST EFFECTIVENESS ANALYSIS authKW 342182 11% 10% 192
2 ECONOMIC EVALUATION authKW 316195 11% 9% 200
3 PHARMACOECONOMICS journal 278358 11% 9% 189
4 MEDICAL DECISION MAKING journal 268148 9% 9% 167
5 HEALTH ECONOMICS journal 243269 9% 9% 163
6 HLTH ECON address 204984 11% 6% 193
7 VALUE OF INFORMATION authKW 197400 4% 16% 74
8 PROBABILISTIC SENSITIVITY ANALYSIS authKW 139412 1% 35% 23
9 NET HEALTH BENEFIT authKW 126163 1% 82% 9
10 VALUE IN HEALTH journal 112283 6% 6% 101

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Health Care Sciences & Services 111780 54% 1% 954
2 Health Policy & Services 91864 37% 1% 666
3 Medical Informatics 40915 19% 1% 334
4 Economics 13110 30% 0% 527
5 Public, Environmental & Occupational Health 2180 15% 0% 273
6 Pharmacology & Pharmacy 1397 18% 0% 327
7 Statistics & Probability 1374 7% 0% 129
8 Mathematical & Computational Biology 1147 5% 0% 88
9 Medicine, General & Internal 518 9% 0% 168
10 Medicine, Research & Experimental 159 5% 0% 84

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HLTH ECON 204984 11% 6% 193
2 BRIGHAM WOMENS FAULKNER NEUROL 102802 0% 100% 6
3 EVALUAT VALUE RISK HLTH 74164 1% 18% 24
4 HLTH ECON EVALUAT TECHNOL ASSESSMENT 51401 0% 100% 3
5 NICE DECIS SUPPORT UNIT 45687 0% 67% 4
6 PHARMACOECONOMICS 34267 0% 100% 2
7 POLICLIN CAREGGI HOSP 34267 0% 100% 2
8 PROGRAM POPULAT HLTH SCI 30447 0% 22% 8
9 MED TECHNOL ASSESSMENT 28129 2% 4% 39
10 PROGRAM ECON EVALUAT MED TECHNOL 28104 0% 21% 8

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PHARMACOECONOMICS 278358 11% 9% 189
2 MEDICAL DECISION MAKING 268148 9% 9% 167
3 HEALTH ECONOMICS 243269 9% 9% 163
4 VALUE IN HEALTH 112283 6% 6% 101
5 INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 68211 4% 5% 75
6 EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH 17798 1% 5% 23
7 EUROPEAN JOURNAL OF HEALTH ECONOMICS 13363 1% 3% 23
8 JOURNAL OF HEALTH ECONOMICS 10258 2% 2% 32
9 STATISTICS IN MEDICINE 8239 3% 1% 59
10 MEDICAL CARE 6594 3% 1% 45

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 COST EFFECTIVENESS ANALYSIS 342182 11% 10% 192 Search COST+EFFECTIVENESS+ANALYSIS Search COST+EFFECTIVENESS+ANALYSIS
2 ECONOMIC EVALUATION 316195 11% 9% 200 Search ECONOMIC+EVALUATION Search ECONOMIC+EVALUATION
3 VALUE OF INFORMATION 197400 4% 16% 74 Search VALUE+OF+INFORMATION Search VALUE+OF+INFORMATION
4 PROBABILISTIC SENSITIVITY ANALYSIS 139412 1% 35% 23 Search PROBABILISTIC+SENSITIVITY+ANALYSIS Search PROBABILISTIC+SENSITIVITY+ANALYSIS
5 NET HEALTH BENEFIT 126163 1% 82% 9 Search NET+HEALTH+BENEFIT Search NET+HEALTH+BENEFIT
6 COST EFFECTIVENESS RATIOS 109653 0% 80% 8 Search COST+EFFECTIVENESS+RATIOS Search COST+EFFECTIVENESS+RATIOS
7 INCREMENTAL NET BENEFIT 109653 0% 80% 8 Search INCREMENTAL+NET+BENEFIT Search INCREMENTAL+NET+BENEFIT
8 OPTIMAL TRIAL DESIGN 102802 0% 100% 6 Search OPTIMAL+TRIAL+DESIGN Search OPTIMAL+TRIAL+DESIGN
9 COST EFFECTIVENESS ACCEPTABILITY CURVES 99124 1% 64% 9 Search COST+EFFECTIVENESS+ACCEPTABILITY+CURVES Search COST+EFFECTIVENESS+ACCEPTABILITY+CURVES
10 MULTINATIONAL STUDIES 85669 0% 100% 5 Search MULTINATIONAL+STUDIES Search MULTINATIONAL+STUDIES

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 RAMSEY, SD , WILLKE, RJ , GLICK, H , REED, SD , AUGUSTOVSKI, F , JONSSON, B , BRIGGS, A , SULLIVAN, SD , (2015) COST-EFFECTIVENESS ANALYSIS ALONGSIDE CLINICAL TRIALS II-AN ISPOR GOOD RESEARCH PRACTICES TASK FORCE REPORT.VALUE IN HEALTH. VOL. 18. ISSUE 2. P. 161 -172 69 50% 26
2 MCGHAN, WF , AL, M , DOSHI, JA , KAMAE, I , MARX, SE , RINDRESS, D , (2009) THE ISPOR GOOD PRACTICES FOR QUALITY IMPROVEMENT OF COST-EFFECTIVENESS RESEARCH TASK FORCE REPORT.VALUE IN HEALTH. VOL. 12. ISSUE 8. P. 1086 -1099 64 81% 30
3 STEUTEN, L , VAN DE WETERING, G , GROOTHUIS-OUDSHOORN, K , RETEL, V , (2013) A SYSTEMATIC AND CRITICAL REVIEW OF THE EVOLVING METHODS AND APPLICATIONS OF VALUE OF INFORMATION IN ACADEMIA AND PRACTICE.PHARMACOECONOMICS. VOL. 31. ISSUE 1. P. 25-48 71 61% 19
4 GREGORI, D , PETRINCO, M , BO, S , DESIDERI, A , MERLETTI, F , PAGANO, E , (2011) REGRESSION MODELS FOR ANALYZING COSTS AND THEIR DETERMINANTS IN HEALTH CARE: AN INTRODUCTORY REVIEW.INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE. VOL. 23. ISSUE 3. P. 331 -341 54 74% 10
5 WILLAN, AR , (2011) SAMPLE SIZE DETERMINATION FOR COST-EFFECTIVENESS TRIALS.PHARMACOECONOMICS. VOL. 29. ISSUE 11. P. 933-949 48 81% 7
6 RAMOS, MCP , BARTON, P , JOWETT, S , SUTTON, AJ , (2015) A SYSTEMATIC REVIEW OF RESEARCH GUIDELINES IN DECISION-ANALYTIC MODELING.VALUE IN HEALTH. VOL. 18. ISSUE 4. P. 512 -529 29 100% 4
7 RAMSEY, S , WILLKE, R , BRIGGS, A , BROWN, R , BUXTON, M , CHAWLA, A , COOK, J , GLICK, H , LILJAS, B , PETITTI, D , ET AL (2005) GOOD RESEARCH PRACTICES FOR COST-EFFECTIVENESS ANALYSIS ALONGSIDE CLINICAL TRIALS: THE ISPOR RCT-CEA TASK FORCE REPORT.VALUE IN HEALTH. VOL. 8. ISSUE 5. P. 521-533 43 61% 299
8 BASTIDA, JL , OLIVA, J , ANTONANZAS, F , GARCIA-ALTES, A , GISBERT, R , MAR, J , PUIG-JUNOY, J , (2010) A PROPOSED GUIDELINE FOR ECONOMIC EVALUATION OF HEALTH TECHNOLOGIES.GACETA SANITARIA. VOL. 24. ISSUE 2. P. 154 -170 35 80% 41
9 JALAL, H , GOLDHABER-FIEBERT, JD , KUNTZ, KM , (2015) COMPUTING EXPECTED VALUE OF PARTIAL SAMPLE INFORMATION FROM PROBABILISTIC SENSITIVITY ANALYSIS USING LINEAR REGRESSION METAMODELING.MEDICAL DECISION MAKING. VOL. 35. ISSUE 5. P. 584 -595 32 82% 3
10 BANG, H , ZHAO, HW , (2014) COST-EFFECTIVENESS ANALYSIS: A PROPOSAL OF NEW REPORTING STANDARDS IN STATISTICAL ANALYSIS.JOURNAL OF BIOPHARMACEUTICAL STATISTICS. VOL. 24. ISSUE 2. P. 443-460 37 74% 3

Classes with closest relation at Level 1


Rank Class id link
1 36936 CASE MIX GROUP CLASSIFICATION//CHARISMA TRIAL//ECON WORKING GRP
2 7853 HEALTH TECHNOLOGY ASSESSMENT//INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE//HTA
3 19841 PHARMACY AND THERAPEUTICS COMMITTEE//FORMULARIES//FORMULARY SYSTEM
4 15740 PRODUCTIVITY COSTS//FINANCIAL TOXICITY//FUTURE COSTS
5 2969 EQ 5D//TIME TRADE OFF//SF 6D
6 37172 COORDENACAO ESTUDOS PESQUISAS SAUDE//DIRETORIA ESTUDOS POLIT SOCIAIS//E HLTH INITIAT
7 22543 DEALE//MEDICAL DECISION MAKING//BIOCHEMISTRY TEST REQUESTING PATTERNS
8 5933 PRIORITY SETTING//RATIONING//ACCOUNTABILITY FOR REASONABLENESS
9 34809 ANNUALIZATION//ASSISTANT PERSONNEL//COST FUNCTION ANALYSIS
10 12293 DIABETES RELATED COMPLICATIONS//COST OF DIABETES CARE//CARDIFF DIABETES MODEL

Go to start page